Format

Send to

Choose Destination
Curr Cardiovasc Imaging Rep. 2010 Feb;3(1):42-49.

Nanomedicine and Cardiovascular Disease.

Author information

1
The Center for Molecular Imaging Research and The Center for Systems Biology, Harvard Medical School and Massachusetts General Hospital, 149 13th Street, 6th Floor, Charlestown, MA 02129, USA.

Abstract

Nanomedicine has become an important tool in the imaging and therapy of numerous diseases. This is due, in large part, to the ability to generate multifunctional nanoagents bearing combinations of targeting, diagnostic, and therapeutic moieties, allowing for the tailoring of the properties of the synthesized nanomaterials. With respect to cardiovascular disease and its sequelae, nanomedicine has the potential to detect and treat some of the leading causes of death and disability in the developed world, including atherosclerosis, thrombosis, and myocardial infarction. As such, this review focuses on some of the most poignant examples of the utility of nanomedicine in the detection and treatment of cardiovascular disease that have been recently reported.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center